Navigation Links
Johns Hopkins researchers suppress 'hunger hormone'
Date:9/15/2008

Johns Hopkins scientists report success in significantly suppressing levels of the "hunger hormone" ghrelin in pigs using a minimally invasive means of chemically vaporizing the main vessel carrying blood to the top section, or fundus, of the stomach. An estimated 90 percent of the body's ghrelin originates in the fundus, which can't make the hormone without a good blood supply.

"With gastric artery chemical embolization, called GACE, there's no major surgery," says Aravind Arepally, M.D., clinical director of the Center for Bioengineering Innovation and Design and associate professor of radiology and surgery at the John Hopkins University School of Medicine. "In our study in pigs, this procedure produced an effect similar to bariatric surgery by suppressing ghrelin levels and subsequently lowering appetite."

Reporting on the research in the September 16 online edition of Radiology, Arepally and his team note that for more than a decade, efforts to safely and easily suppress grehlin have met with very limited success.

Bariatric surgery - involving the removal, reconstruction or bypass of part of the stomach or bowel - is effective in suppressing appetite and leading to significant weight loss, but carries substantial surgical risks and complications. "Obesity is the biggest biomedical problem in the country, and a minimally invasive alternative would make an enormous difference in choices and outcomes for obese people," Arepally says.

Arepally and colleagues conducted their study over the course of four weeks using 10 healthy, growing pigs; after an overnight fast, the animals were weighed and blood samples were taken to measure baseline ghrelin levels. Pigs were the best option, he says, because of their human-like anatomy and physiology.

Using X-ray for guidance, members of the research team threaded a thin tube up through a large blood vessel near the pigs' groins and then into the gastric arteries s
'/>"/>

Contact: Maryalice Yakutchik
myakutc1@jhmi.edu
443-287-2251
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Johns Hopkins receives $100 million grant to speed research from clinic to community
5. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
8. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
9. In Johnstown Governor Rendell Launches Tour to Insure; Urges Passage of Plan to Give Access to Affordable Health Insurance
10. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
11. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...swire/ -- HUYA Bioscience International, a leade...ion, today announced a strategic partnership with ...ity of China. The agreement is another in a series...China,s leading research and development instituti...t and commercialization of novel biopharmaceutical...
(Date:11/9/2009)...y involving 2,453 women ages 18 to 68 found that l...a partner contributed to higher ratings of pleasur...have long been recommended to women to improve the...isk of vaginal tearing, yet strikingly little avai...ts or associated vaginal symptoms. , The study,...
(Date:11/8/2009)...Newswire-USNewswire/ -- The American Public Health...llness provisions in the health reform bill passed...his bill, the House takes important steps toward u...reforms and moving our health system from one that...on keeping people healthy," said Georges C. Benjam...
(Date:11/8/2009)... out of the game later, doctors say , , ...re the talk of the NFL this season, sidelining suc...k Willie Parker. , Officials at the American Po...f Podiatric Sports Medicine are warning athletes t...ts like football and lacrosse. , "Many fall spo...
(Date:11/8/2009)...book called "Preventing and Healing AIDS Thro...o shows that AIDS is a result of multiple, repeate...mmune system stressor agents, which can be either ...motional. , Oakland, CA ... 2009, cell biologists, physicians, chemists and o...
Breaking Medicine News(10 mins):Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
...0 Jobs, HARRISBURG, Pa., Dec. 28 /PRNewswire-USNe...e Williamsport Hospital and Medical Center campus,... a $12.5 million grant,from the commonwealth, the ...ears -- for debt service to the Lycoming County In...
...,Acquisition Corp. ("Echo" or the "Company") (OTC ...unced at its special meeting of stockholders today... provide stockholders,additional time to consider ...us previously mailed to Echo stockholders.,The Ech...
...ission,to provide service, support and hope to all... America (LFA) submitted comments today to Commiss...stration (SSA), regarding a,proposed change to the...be submitted 5 days,before an administrative heari...
...helped for at least a decade , , FRIDAY, D...ly and safely corrects severe myopia for at least ...pia, which is caused by excessive curving of the e...from some degree of nearsightedness. , Laser surge...
...Year,s as the,"world championship" of weight loss,...nd promises. For millions of well-intentioned diet... and, ultimately,disappointment., (See video fro...mber,by Harris Interactive(R) on behalf of GlaxoSm...
... A review published in Dermatologic Therapy revea... procedures in the same way as women but require h...here has recently become a growing interest in cos... often require more units of Botox than women whic...
Other Medicine News:Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 2Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 3Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 4Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 5Health News:Lupus Foundation of America Urges Social Security Administration Not to Adopt Proposed 5-Day Rule 2Health News:Laser Surgery Can Correct Nearsightedness 2Health News:VIDEO from Medialink and GlaxoSmithKline: Really Think You Can 'Lose 30 Pounds in 30 Days?' 2
(Date:11/6/2009)...re-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX )...ncial results for the second quarter ended October... on Wednesday, November 18, 2009 at 5:00 PM EST. ...uss those results on Thursday, November 19, 2009 a...rter Results Conference Call Instructions ,, ...
(Date:11/6/2009)...re-FirstCall/ -- Caraco Pharmaceutical Laboratorie...tromethamine ophthalmic solution, 0.5% following a...ration (FDA) for Sun Pharma,s Abbreviated New Drug...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: ...c products for regenerative healing, today reporte...ptember 30, 2009. ,, "During the third quarter ... new biologic products MagniFuse(TM) Bone Graft, ... Innovative Grafting," said Sam Owusu-Akyaw, Presi...
Breaking Medicine Technology:Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 1New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 3New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 4New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 5Social background weighs heavily on teenage diet 58327 1Social background weighs heavily on teenage diet 58327 2New Treatment May Beat Melanoma 58326 1New Treatment May Beat Melanoma 58326 2New Treatment May Beat Melanoma 58326 3
...rk Hurtt, Chief Medical Officer, to present interi... Trial in Acute Spinal Cord Injury, HOPKINTON, Ma...(Nasdaq: ALSE ) announced that on April 15, 2008,...ss the CETHRIN development,program as a member of ...ing a congressional briefing on Capitol Hill focus...
...EGO, April 9, 2008 Favrille, Inc.,(Nasdaq: FVRL ...specific,active immunotherapies for the treatment ... data cutoff date for the Company,s Phase 3 regist...merly FavId(R)) following,Rituxan(R) in patients w....,As of the data cutoff date, 205 of the 349 patie...
Other Medicine Technology:Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 2Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 3Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 4Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 2Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 3Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 4Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June 5
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: